New frontiers in CLTI treatment: The onward march below the knee

Marianne Brodmann (Medical University of Graz, Graz Austria) sat down with Vascular News at CX 2026 to talk below-knee peripheral arterial disease (PAD) treatment and how it is improving off the back of developments in vessel preparation and, importantly, she says, bioresorbable scaffolds. With the addition of a “working” drug-coated balloon (DCB) for the treatment of chronic limb-threatening ischaemia (CLTI) below the knee, and Brodmann envisages a robust armamentarium emerging. The final frontier in below-knee care, she adds, remains below the ankle.